SH
LABU icon

SLT Holdings’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

SLT Holdings’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,000
Closed -$797K – 150
2025
Q4 		$797K Buy
+5,000
New +$687K 0.51% 46

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

SLT Holdings's LABU Position: Q1 2026 in Review

SLT Holdings sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026, closing a stake of 5,000 shares — an estimated $797K sold.

SLT Holdings first reported a position in LABU in Q4 2025 and held it in 1 quarter. The position peaked at $797K in Q4 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • SLT Holdings reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
  • SLT Holdings sold 5,000 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $797K.
  • SLT Holdings first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2025 and held it in 1 quarter.
  • SLT Holdings's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $797K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on SLT Holdings's 13F filing for Q1 2026, filed 21 Apr 2026.